Elotuzumab Intravenous and Insulin glargine
Determining the interaction of Elotuzumab Intravenous and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: elotuzumab
Brand name: Empliciti
Synonyms: Elotuzumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elotuzumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Elotuzumab Intravenous-Insulin Glargine (U-100) Vials
- Elotuzumab Intravenous-Insulin Glargine (U-300) Pens
- Elotuzumab Intravenous-Insulin glargine and lixisenatide
- Elotuzumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Elotuzumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Eloxatin
- Insulin glargine-Elppa CoQ10 coenzyme Q-10
- Insulin glargine-Elspar
- Insulin glargine-Elta SilverGel
- Insulin glargine-Elta Tar
- Insulin glargine-Eltrombopag